FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891776482> ?p ?o ?g. }

• W2891776482 endingPage "596.e3" @default.
• W2891776482 startingPage "589" @default.
• W2891776482 abstract "An estimated 7% of patients with asthma have chronic rhinosinusitis with nasal polyps (CRSwNP), and more than 80% have at least some radiographic evidence of sinonasal inflammation. Aspirin sensitivity is strongly associated with elevated blood eosinophil levels and increased asthma severity. Intravenous (IV) reslizumab has been shown to improve asthma control in patients with nasal polyps.These post hoc analyses of pooled data from 2 BREATH phase 3 clinical trials, studies 1 and 2 (NCT01287039 and NCT01285323), examined asthma-related outcomes in patients with comorbid, self-reported CRSwNP with and without aspirin sensitivity.Patients aged 12-75 years with elevated blood eosinophils (≥400 cells/μL) and inadequately controlled asthma were randomized to receive placebo or reslizumab (3 mg/kg IV) every 4 weeks for 52 weeks. Patients continued their background asthma maintenance therapy during the study. Information regarding the presence of CRSwNP was obtained through patient-reported medical history.Add-on reslizumab treatment reduced the frequency of clinical asthma exacerbations by 83% versus placebo among patients with CRSwNP. Among patients with and without aspirin sensitivity, reductions of 79% and 84%, respectively, were observed. Patients with CRSwNP (with and without aspirin sensitivity) treated with reslizumab add-on therapy also had significant improvements in lung function, as measured by forced expiratory volume in 1 second, compared with placebo. Among patients with CRSwNP, reslizumab was also associated with improvements in patient-reported asthma control and asthma quality of life.Patients with eosinophilic asthma and self-reported CRSwNP, with and without aspirin sensitivity, are highly responsive to treatment with reslizumab for asthma-related outcomes. These findings suggest that prospective investigation of reslizumab in this patient population is warranted." @default.
• W2891776482 created "2018-09-27" @default.
• W2891776482 creator A5003040664 @default.
• W2891776482 creator A5007368926 @default.
• W2891776482 creator A5026100618 @default.
• W2891776482 creator A5026855898 @default.
• W2891776482 creator A5050732025 @default.
• W2891776482 creator A5056192386 @default.
• W2891776482 creator A5075773797 @default.
• W2891776482 creator A5083755188 @default.
• W2891776482 creator A5090062530 @default.
• W2891776482 date "2019-02-01" @default.
• W2891776482 modified "2023-10-06" @default.
• W2891776482 title "Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps" @default.
• W2891776482 cites W1457050190 @default.
• W2891776482 cites W1482910782 @default.
• W2891776482 cites W1606887512 @default.
• W2891776482 cites W1885435857 @default.
• W2891776482 cites W1916962812 @default.
• W2891776482 cites W1943316663 @default.
• W2891776482 cites W1966013656 @default.
• W2891776482 cites W1968876836 @default.
• W2891776482 cites W1979554183 @default.
• W2891776482 cites W1982941253 @default.
• W2891776482 cites W1987677268 @default.
• W2891776482 cites W1993094262 @default.
• W2891776482 cites W1998874063 @default.
• W2891776482 cites W2002980147 @default.
• W2891776482 cites W2004627112 @default.
• W2891776482 cites W2019535648 @default.
• W2891776482 cites W2021307666 @default.
• W2891776482 cites W2021371448 @default.
• W2891776482 cites W2026583845 @default.
• W2891776482 cites W2027722615 @default.
• W2891776482 cites W2039439214 @default.
• W2891776482 cites W2039930386 @default.
• W2891776482 cites W2042059115 @default.
• W2891776482 cites W2045356628 @default.
• W2891776482 cites W2057157523 @default.
• W2891776482 cites W2074897148 @default.
• W2891776482 cites W2086167722 @default.
• W2891776482 cites W2091722094 @default.
• W2891776482 cites W2096144342 @default.
• W2891776482 cites W2099873243 @default.
• W2891776482 cites W2124204692 @default.
• W2891776482 cites W2151079173 @default.
• W2891776482 cites W2221351268 @default.
• W2891776482 cites W2266684950 @default.
• W2891776482 cites W2309688181 @default.
• W2891776482 cites W2324417905 @default.
• W2891776482 cites W2338443462 @default.
• W2891776482 cites W2463242228 @default.
• W2891776482 cites W2471128678 @default.
• W2891776482 cites W2486722911 @default.
• W2891776482 cites W2585010481 @default.
• W2891776482 cites W2730614382 @default.
• W2891776482 cites W2739450515 @default.
• W2891776482 cites W4254446533 @default.
• W2891776482 doi "https://doi.org/10.1016/j.jaip.2018.08.021" @default.
• W2891776482 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30193936" @default.
• W2891776482 hasPublicationYear "2019" @default.
• W2891776482 type Work @default.
• W2891776482 sameAs 2891776482 @default.
• W2891776482 citedByCount "61" @default.
• W2891776482 countsByYear W28917764822019 @default.
• W2891776482 countsByYear W28917764822020 @default.
• W2891776482 countsByYear W28917764822021 @default.
• W2891776482 countsByYear W28917764822022 @default.
• W2891776482 countsByYear W28917764822023 @default.
• W2891776482 crossrefType "journal-article" @default.
• W2891776482 hasAuthorship W2891776482A5003040664 @default.
• W2891776482 hasAuthorship W2891776482A5007368926 @default.
• W2891776482 hasAuthorship W2891776482A5026100618 @default.
• W2891776482 hasAuthorship W2891776482A5026855898 @default.
• W2891776482 hasAuthorship W2891776482A5050732025 @default.
• W2891776482 hasAuthorship W2891776482A5056192386 @default.
• W2891776482 hasAuthorship W2891776482A5075773797 @default.
• W2891776482 hasAuthorship W2891776482A5083755188 @default.
• W2891776482 hasAuthorship W2891776482A5090062530 @default.
• W2891776482 hasConcept C126322002 @default.
• W2891776482 hasConcept C142724271 @default.
• W2891776482 hasConcept C203014093 @default.
• W2891776482 hasConcept C204787440 @default.
• W2891776482 hasConcept C27081682 @default.
• W2891776482 hasConcept C2776042228 @default.
• W2891776482 hasConcept C2777628954 @default.
• W2891776482 hasConcept C2777768476 @default.
• W2891776482 hasConcept C2781390199 @default.
• W2891776482 hasConcept C71924100 @default.
• W2891776482 hasConcept C90924648 @default.
• W2891776482 hasConceptScore W2891776482C126322002 @default.
• W2891776482 hasConceptScore W2891776482C142724271 @default.
• W2891776482 hasConceptScore W2891776482C203014093 @default.
• W2891776482 hasConceptScore W2891776482C204787440 @default.
• W2891776482 hasConceptScore W2891776482C27081682 @default.
• W2891776482 hasConceptScore W2891776482C2776042228 @default.
• W2891776482 hasConceptScore W2891776482C2777628954 @default.
• W2891776482 hasConceptScore W2891776482C2777768476 @default.

• next